OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO(TM)
Stock Information for OncoSec Medical Incorporated
Loading
Please wait while we load your information from QuoteMedia.